Inventor · disambiguated record
David Uehling
Also filed as: UEHLING DAVID · UEHLING DAVID E · UEHLING DAVID EDWARD
12 granted patents·11 pending applications·93 citations·filing 1999–2023
89Inventor score
Files withONTARIO INSTITUTE FOR CANCER RES OICR8PROPELLON THERAPEUTICS INC4ADJABENG GEORGE2GLAXOSMITHKLINE LLC2DEATON DAVID N1
Top patents by PatentIndex Score
23 records- 0190US8415345B2Benzene sulfonamide thiazole and oxazole compoundsADJABENG GEORGE·Filed 2009·Granted Apr 9, 2013·26 cites·14 claims
- 0283US7812022B22-pyrimidinyl pyrazolopyridine ErbB kinase inhibitorsGLAXOSMITHKLINE LLC·Filed 2005·Granted Oct 12, 2010·8 cites·15 claims
- 0383US7034053B2Phenethanolamine derivatives, compositions, and their use as agonists at atypical beta-adrenoreceptorsSMITHKLINE BEECHAM CORP·Filed 2001·Granted Apr 25, 2006·11 cites·11 claims
- 0480US11518764B2Substituted heteroaryls as inhibitors of the BCL6 BTB domain protein-protein interactionONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2019·Granted Dec 6, 2022·3 cites·18 claims
- 0579US11174250B2Substituted carboxamides as inhibitors of WDR5 protein-protein bindingPROPELLON THERAPEUTICS INC·Filed 2017·Granted Nov 16, 2021·3 cites·23 claims
- 0678US11364234B2Compounds and methods for treating nematode infectionsGOVERNING COUNCIL UNIV TORONTO·Filed 2019·Granted Jun 21, 2022·1 cites·20 claims
- 0778US7807673B22-pyrimidinyl pyrazolopyridine ErbB kinase inhibitorsGLAXOSMITHKLINE LLC·Filed 2006·Granted Oct 5, 2010·7 cites·25 claims
- 0870US8093239B2Imidazopyridine kinase inhibitorsKUNTZ KEVIN·Filed 2008·Granted Jan 10, 2012·2 cites·37 claims
- 0968US11319299B2Substituted carboxamides as inhibitors of WDR5 protein-protein bindingPROPELLON THERAPEUTICS INC·Filed 2017·Granted May 3, 2022·1 cites·39 claims
- 1068US6251925B1Therapeutic biaryl derivativesGLAXO WELLCOME INC·Filed 1999·Granted Jun 26, 2001·31 cites·17 claims
- 1162US2025154140A1Isoquinoline derivatives as inhibitors of bax and/or bak, compositions and uses thereofSUNNYBROOK RES INST·Filed 2023·Application pending·0 cites
- 1261US12264147B2Substituted carboxamides as inhibitors of WDR5 protein-protein bindingPROPELLON THERAPEUTICS INC·Filed 2022·Granted Apr 1, 2025·0 cites·2 claims
- 1356US2024343704A1Halo-substituted amino pyridine compounds as inhibitors of the haematopoietic progenitor kinase 1 (hpk1)ONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2022·Application pending·0 cites
- 1455US2006148887A1Chemical compoundsDEATON DAVID N·Filed 2006·Application pending·0 cites
- 1555US2024425479A1Halo-substituted amino aza-heteroaryl compounds as inhibitors of the haematopoietic progenitor kinase 1 (hpk1)ONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2022·Application pending·0 cites
- 1654US2024317723A1Substituted amino aza-heteroaryl compounds as inhibitors of the haematopoietic progenitor kinase 1 (hpk1)ONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2022·Application pending·0 cites
- 1753US2024092763A1Isoindolinone aminopyrimidine compounds as inhibitors of nuak kinases, compositions and uses thereofONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2022·Application pending·0 cites
- 1853US2024025887A1Thienyl and cycloalkyl aminopyrimidine compounds as inhibitors of nuak kinases, compositions and uses thereofONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2022·Application pending·0 cites
- 1949US2022267281A1Unsaturated heterocycloalkyl and heteroaromatic acyl hydrazone linkers, methods and uses thereofONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2020·Application pending·0 cites
- 2045US2020385371A1Inhibitors of wdr5 protein-protein bindingPROPELLON THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2144US2011190280A1Thiazole And Oxazole Kinase InhibitorsADJABENG GEORGE·Filed 2008·Application pending·0 cites
- 2242US11242351B2Tricyclic inhibitors of the BCL6 BTB domain protein-protein interaction and uses thereofONTARIO INSTITUTE FOR CANCER RES OICR·Filed 2018·Granted Feb 8, 2022·0 cites·14 claims
- 2337US2005009845A1Thienopyrimidine compounds as protein tyrosine kinase inhibitorsFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →